These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10716061)

  • 21. LC determination of the diastereomers of 1-(beta-D-glucopyranosyl)phenobarbital in human urine.
    Soine WH; Soine PJ; England TM; Welty DF; Wood JH
    J Pharm Biomed Anal; 1990; 8(4):365-72. PubMed ID: 2100211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of lactation on plasma phenobarbital concentrations in rats.
    Moriyama M; Yamashita S; Furuno K; Sato T; Domoto H; Yamatogi Y; Kawasaki H; Gomita Y
    Jpn J Pharmacol; 1997 Mar; 73(3):191-6. PubMed ID: 9127813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free drug levels monitoring as a detector of false metabolic refractory epilepsy.
    Gianelli M; Gentile S; Verzè L; Dimanico U; Baruchello M; Monaco F; Mutani R
    Eur Neurol; 1988; 28(6):349-53. PubMed ID: 3215211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of phenobarbital in patients with refractory status epilepticus undergoing therapeutic plasma exchange.
    Wang SN; Gu CP; Liu GH; Lin ZZ; Zheng P; Pan SY; Liu ST
    Neuroreport; 2018 Nov; 29(16):1360-1364. PubMed ID: 30216211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus.
    Hovinga CA; Chicella MF; Rose DF; Eades SK; Dalton JT; Phelps SJ
    Ann Pharmacother; 1999 May; 33(5):579-84. PubMed ID: 10369622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of non-intravenous high-dose phenobarbital therapy for intractable epilepsy during childhood.
    Kikuchi K; Hamano S; Oritsu T; Koichihara R; Tanaka M; Minamitani M; Ida H
    Brain Dev; 2011 May; 33(5):379-83. PubMed ID: 20724088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics of agents used to treat status epilepticus.
    Browne TR
    Neurology; 1990 May; 40(5 Suppl 2):28-32. PubMed ID: 2185438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)--a nationwide questionnaire survey in Japan.
    Tanabe T; Awaya Y; Matsuishi T; Iyoda K; Nagai T; Kurihara M; Yamamoto K; Minagawa K; Maekawa K
    Brain Dev; 2008 Nov; 30(10):629-35. PubMed ID: 18424028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus.
    Brigo F; Igwe SC; Nardone R; Tezzon F; Bongiovanni LG; Trinka E
    Epileptic Disord; 2013 Sep; 15(3):314-23. PubMed ID: 23981687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mega-dose phenobarbital therapy for super-refractory status epilepticus.
    Byun JI; Chu K; Sunwoo JS; Moon J; Kim TJ; Lim JA; Jun JS; Lee HS; Lee WJ; Lee DY; Jeon D; Lee ST; Jung KH; Jung KY; Lee SK
    Epileptic Disord; 2015 Dec; 17(4):444-52. PubMed ID: 26575689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased sensitivity to the anesthetic effect of phenobarbital in aging BN/BiRij rats.
    Stijnen AM; Danhof M; Van Bezooijen CF
    J Pharmacol Exp Ther; 1992 Apr; 261(1):81-7. PubMed ID: 1560386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of felbamate on the pharmacokinetics of phenobarbital.
    Reidenberg P; Glue P; Banfield CR; Colucci RD; Meehan JW; Radwanski E; Mojavarian P; Lin CC; Nezamis J; Guillaume M
    Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characteristics of drugs used in the treatment of acute convulsions and convulsive status].
    Herranz JL; Argumosa A
    Rev Neurol; 2000 Oct 16-31; 31(8):757-62. PubMed ID: 11082886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phenobarbital coma for psychogenic status epilepticus].
    Taliansky A; Kramer U; Neufeld MY
    Harefuah; 2000 Feb; 138(4):294-6, 342. PubMed ID: 10883115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-intravenous high-dose phenobarbital therapy for status epilepticus refractory to continuous infusion of midazolam or pentobarbital: report of three cases].
    Sudoh A; Sugai K; Miyamoto T; Mimaki M; Fukumizu M; Hanaoka S; Sasaki M
    No To Hattatsu; 2002 Jan; 34(1):23-9. PubMed ID: 11808203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus.
    Mawasi H; Bibi D; Shekh-Ahmad T; Shaul C; Blotnik S; Bialer M
    Mol Pharm; 2016 Jul; 13(7):2492-6. PubMed ID: 27218460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus.
    Ulvi H; Yoldas T; Müngen B; Yigiter R
    Neurol Sci; 2002 Oct; 23(4):177-82. PubMed ID: 12536286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.